INS and fatty liver disease: Emerging evidence indicates a pivotal role of LTB4 in insulin resistance and hepatic steatosis, with LTB4 directly enhancing macrophage chemotaxis, reducing insulin-stimulated glucose uptake in myocytes, and inhibiting insulin-mediated suppression of hepatic glucose output (Li et al., 2015).